Interview with Dr. Michelle Krishnan: New Therapies for Neurodevelopmental Disorders
Front Line Genomics has recently interviewed Dr. Michelle Krishnan, who is the Translational Medicine Leader in Rare Diseases at Roche. She focuses on rare neurodevelopmental disorders, in which she works…